The Food and Drug Administration, headquartered in Silver Spring, Md., has authorized ImmunityBio of El Segundo to begin a Phase 1 clinical trial for its coronavirus vaccine candidate. ImmunityBio, an El Segundo biotech company headed by Dr. Patrick Soon-Shiong, said Thursday it had received approval from the Food and Drug Administration to begin preliminary testing of the company’s COVID-19 vaccine …
